Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target-Reference-Cited by-同舟云学术

Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target

Published:2018-04 Issue: Volume:130 Page:374-384
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Caraci Filippo,Spampinato Simona Federica,Morgese Maria Grazia,Tascedda Fabio,Salluzzo Maria Grazia,Giambirtone Maria Concetta,Caruso Giuseppe,Munafò Antonio,Torrisi Sebastiano Alfio,Leggio Gian Marco,Trabace Luigia,Nicoletti Ferdinando,Drago Filippo,Sortino Maria Angela,Copani Agata

Publisher

Elsevier BV

Subject

Pharmacology

Reference169 articles.

1. Neuropsychiatric signs and symptoms of Alzheimer's disease: new treatment paradigms;Lanctot;Alzheimer's Dement.,2017

2. Apathy and depression in mild Alzheimer's disease: a cross-sectional study using diagnostic criteria;Benoit;J. Alzheimer's Dis. JAD,2012

3. Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study;Steinberg;Int. J. Geriatr. Psychiatry,2006

4. A common challenge in older adults: classification, overlap, and therapy of depression and dementia;Leyhe;Alzheimer's Dement.,2017

5. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets;Caraci;Eur. J. Pharmacol.,2010

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1;Journal of Affective Disorders;2024-12

2. Ketamine and new targets for treatment-resistant depression: A role for transforming growth factor-β1?;European Neuropsychopharmacology;2024-09

3. Activation of astrocytic NMDA receptors counteracted Aβ-induced reduction of BDNF and elevation of GFAP and complement 3 in the hippocampal astrocytes;Neuroscience;2024-09

4. Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?;Journal of Neuroinflammation;2024-07-30

5. Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology;Cells;2024-07-08